Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medical therapy for ischemic stroke

B Silver1, J Weber, M Fisher

  • 1Department of Neurology, Medical Center of Central Massachusetts, Worcester 01605, USA.

Clinical Neuropharmacology
|April 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acceptability and feasibility of recruiting women to collect a self-administered vaginal swab at a pharmacy clinic for sexually transmissible infection screening.

Sexual health·2020
Same author

Accuracy of automated three-dimensional ultrasound imaging technique for fetal head biometry.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2020
Same author

Looking beyond the ovary for oncofertility care in women: uterine injury as a potential target for fertility-preserving treatments.

Journal of assisted reproduction and genetics·2020
Same author

Leukoaraiosis Attenuates Diagnostic Accuracy of Large-Vessel Occlusion Scales.

AJNR. American journal of neuroradiology·2017
Same author

Clinical performance of the Solana® Point-of-Care Trichomonas Assay from clinician-collected vaginal swabs and urine specimens from symptomatic and asymptomatic women.

Expert review of molecular diagnostics·2017
Same author

Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected and uninfected women from Brazil.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2013
Same journal

Characterization of Propranolol Use and Outcomes in Traumatic Brain Injury at a Level I Trauma Center.

Clinical neuropharmacology·2026
Same journal

Review of Medications That Reduce Neurological Deficits in Patients With Traumatic Brain Injury.

Clinical neuropharmacology·2026
Same journal

Pre-Existing Peak-Dose Dyskinesia and Light Body Weight as Predictors of Ropinirole Patch Dose Modification in Parkinson Disease: A Multicenter Retrospective Study.

Clinical neuropharmacology·2026
Same journal

A Double-blind, Placebo-controlled Study of Lumateperone in the Treatment of Borderline Personality Disorder.

Clinical neuropharmacology·2026
Same journal

Yesterday Once More: Revisiting Catatonia in an Elderly Stroke Patient.

Clinical neuropharmacology·2026
Same journal

Overlapping Hyperosmolar Therapy in Patients With Elevated and Refractory Intracranial Pressure.

Clinical neuropharmacology·2026
See all related articles

Stroke therapy is rapidly evolving, mirroring heart attack treatments. New research focuses on acute interventions using cytoprotective drugs and thrombolytic agents to prevent cell death and dissolve clots.

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Stroke therapy is undergoing significant advancements, paralleling progress in myocardial infarction treatment.
  • Acute interventions and preventive strategies are key areas of focus.

Purpose of the Study:

  • To review current and emerging therapies for stroke, including cytoprotective and thrombolytic agents.
  • To discuss the evaluation of thrombolytic drugs and preventive therapies like antiplatelet and anticoagulant medications.

Main Methods:

  • Review of active investigations into cytoprotective agents targeting ischemia and reperfusion.
  • Evaluation of thrombolytic agents (e.g., t-PA, urokinase) for stroke treatment.
  • Assessment of preventive strategies including antiplatelet and anticoagulant drugs.

Related Experiment Videos

Main Results:

  • Cytoprotective therapies aim to prevent cell death using diverse mechanisms (e.g., channel antagonists, antioxidants).
  • Thrombolytic agents are being evaluated for efficacy in stroke, similar to their use in myocardial infarction.
  • Preventive therapies are crucial for risk-benefit stratification in stroke patients.

Conclusions:

  • Stroke treatment is rapidly advancing with new pharmacological approaches.
  • Public education is essential to support the integration of these new stroke therapies.